Skip to search.
 TSX Down 0.90% TSX Ventures Down 1.16%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
127.11 Down 0.08(0.06%) May 26, 4:00PM EDT
Add to Portfolio
Prev Close:127.19
Open:127.00
Bid:112.10 x 300
Ask:N/A
1y Target Est:131.11
Beta:1.05
Earnings Date:Jul 28 - Aug 3 (Est.)
Day's Range:125.46 - 128.74
52wk Range:55.36 - 133.54
Volume:1,047,704
Avg Vol (3m):1,548,470
Market Cap:20.38B
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNDown 0.06%20.38B
FOLDUp 2.81%1.13B
SHPGDown 1.52%50.30B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.40
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.15
Quarterly EPS Est (Jun-15) :-0.53
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-2.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback